BOULDER, Colo.--(BUSINESS WIRE)--Feb. 6, 2008--Array BioPharma
Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer,
Robert E. Conway, will speak at the 2008 BIO CEO & Investor Conference
on February 12 in New York City. The public is welcome to participate
in the conference through an audio webcast on the Array BioPharma
website.
Event: 2008 BIO CEO & Investor Conference
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Tuesday, February 12, 2008
Time: 11:00 a.m. Eastern Time
Location: Waldorf=Astoria Hotel, New York City
Audio Webcast: www.arraybiopharma.com
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small
molecule drugs to treat patients afflicted with cancer, inflammatory
diseases and pain. Our proprietary drug development pipeline includes
clinical candidates that are designed to regulate therapeutically
important target proteins and are aimed at large market opportunities.
In addition, leading pharmaceutical and biotechnology companies
collaborate with Array to discover and develop drug candidates across
a broad range of therapeutic areas. For more information on Array,
please go to www.arraybiopharma.com.
CONTACT: Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com
SOURCE: Array BioPharma Inc.
